... diseases. In addition, many oral therapies are being researched in the areas of RA, Psoriasis, and MS. Stem cell research will also be represented well in 2013. Investors continue to be unafraid of the lengthy and difficult process to achieve FDA ...
http://www.sys-con.com/node/2512198
http://www.sys-con.com/node/2512198
No comments:
Post a Comment